DEF 14A Filing

Company

Celldex Therapeutics, Inc.

Filed

April 3, 2001

Period of Report

May 21, 2001

Accession Number

0001053949-01-500039

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →